Long term efficacy and safety of nimotuzumab in unresectable locally advanced squamous cell carcinoma of head and neck: A real world Indian experience.

e18077Background: Nimotuzumab is an anti-EGFR monoclonal antibody approved for the treatment of head and neck cancer (HNC) in India and 20 other countries. However, available evidence on long term ...